Informing Spectroscopists for Over 40 Years

Benefits of MRI as a prostate cancer screening tool

14 October 2020 | News
by Ian Michael

Multiparametric magnetic resonance imaging of the prostate (mpMRIp) is a promising tool for diagnosing prostate cancer. Prior to its availability, detection relied on clinical examinations and prostate specific antigen (PSA) screening. In a study published in BJU International, investigators found that the availability of mpMRIp in Australia since 2012 has correlated with significantly reduced numbers of prostate biopsies by an average of 354.7 per month, with an estimated annual saving of $13.2 million.

“Our research shows publicly funded prostate MRI not only represents good policy in terms of health equity, but it also makes sense from a financial perspective”, said lead author Thomas Whish-Wilson, BBiomedSc, MD, of St Vincent’s Hospital Melbourne and The University of Melbourne, in Australia.

Rate this Article: 
No votes yet
Technique: